drugset / Trial / NCT01398280

Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

NCT01398280

Phase 0 Completed 15 enrolled University of California, San Diego
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to determine the effect of topical aminocaproic acid on the immune system by assessing the levels of antimicrobial peptides in the skin of patients with rosacea. It is hypothesized that aminocaproic acid applied topically will alter the body's immune system in patients with rosacea by inhibiting activation of antimicrobial peptides.

Timeline

Start
2011-07
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminocaproic Acid Small molecule 25 % Topical

Indications